$HHSE:..Hannover-House - Status-Update for

New Post Public Reply Private Reply Replies (0) Message Board
HHSErocks jmtimz #89059
107
$HHSE:..Hannover-House - Status-Update for Shareholders


Friday, January 31, 2025

(Click on link to view photos)


http://hannoverhousemovies.blogspot.com/2025/...e-for.html



Greetings HHSE Friends & Followers - So many exciting things in motion at this time! As requested by some HHSE Longs - here's a quick recap of key items and projects:

1). TRUMP BOOK - Author Barr McClellan asked to add new material in order to cover the historic Inaugural week, plus " Promises Made, Promises Kept" (delivery on campaign pledges) , as well as a recap summary chapter called "American Manifesto ." These changes and additions will enhance the newsworthiness and shelf-life of the book - elevating it to a more lasting historical record. There will be about a 3-week delay in both the e-book and hardcover editions.... but in the scope of long-term values, we felt that this was a modest delay for a longer-term gain. Meanwhile PRESALES are ASTOUNDING!



2). UNHOLY SONG
- This is turning into a MAJOR SURPRISE HIT for HHSE. This low-budget horror thriller is the first title under our newly resurrected "releasing brand" of HEMDALE (the multi-Oscar winning indie studio where Hannover House CEO Eric Parkinson was previously CEO) . The teaser trailer has already generated over 7-million total views (mostly via "X" posts and boosted ads) - which is a terrific sign of consumer interest. The film opens in theatres Feb. 28. FOR THE FIRST TIME EVER for a Hannover House release, Fandango and Rotten Tomatoes have ALREADY launched the title page ... a full four weeks prior to the film's release! Watch for some jaw-dropping PUBLICITY over the next few weeks... we won't tell you what to watch for in advance.. we'll just SHOW YOU with the photos and video links!


3). HHSE UPLIST - At long last, we are filing the application to uplist to the OTC: QB. Our plan to do this in January was not met, but our commitment remains. There have been some issues to resolve including the refiling of some prior years 1120 corporate tax returns. But we are close to completion, and look forward to the days in which high-volume traders will step-up to support the HHSE stock growth.


4). WILDFIRE - As stated last week, the final theatrical mixing and mastering was completed in Los Angeles.. . and the film is presently in " delivery mode" to turn this asset into positive cash flow. Some HHSE Longs asked for an explanation of how a Special Purpose Entity such as SNOWY MORNING, INC. is related to a parent organization such as HHSE - and how the transference and capitalization of the balance sheet asset works? We realize that none of our HHSE shareholders (and none of the chat-room posters) have ever actually produced a movie, so this logistics question is understandably an unknown to non-industry professionals. But every major studio and distributor involved in feature productions uses "SPE" Special Purpose Entities for the physical production of features. This is an important step for both signatory status to guilds, as well as for arm's-length protection of the affiliate studio from any liens or liabilities that sometimes occur with feature productions. Once a film is completed and cleared, the asset is moved to the studio owner / distributor.


5). OTHER BIG STUFF - We are preparing for the production shoot of INDIAN TERRITORY - as well as in Pre-Production (in Malta) with TEMPUS PORTA , and a privately funded Native American comedy, HARD TIMES IN T-TOWN. The company is also "almost" finished with the production of NATIVE FABLES - and will have this fully ready in May for the CANNES FILM FESTIVAL (including one of the segments in the short-film showcase competition!).

Last but not least... the MYFLIX Streaming Service is positioned to LAUNCH. .. we have been awaiting FINANCIAL RESOURCES to assure a success. With deliveries now commencing for WILDFIRE - as well as TRUMP book presales strong and ticket demand for UNHOLY SONG strong - we feel the company will be well-positioned to self-finance the MYFLIX launch in the coming months!
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Vylor's $3 Billion Buyback: A Long-Term Bet

Updated Category News Views 7

Pumping Confidence with a Massive Buyback Vylor's big move to throw $3 billion into a share buyback isn't about short-term antics. This company's doubling down on long-term value creation, making sure every stakeholder knows they're in for the long haul. It's a gutsy move but what this step really tells us is, they've got faith in the business and a balance sheet that can...

Continue Reading
Anavex Faces Securities Lawsuit: Investor Implications

Updated Category News Views 0

Storm Clouds Over Anavex: What Investors Need to Know If you've got a slice of Anavex Life Sciences Corp. (NASDAQ: AVXL) in your portfolio, the latest chapter of their legal saga feels less like a twist and more like a twist of the knife. These lawsuits often come out of left field for investors, but this one seems like a slow train that’s been gathering steam for a...

Continue Reading
Tigo Energy Faces Class Action Over Revenue Claims

Updated Category News Views 4

Trouble Brewing for Tigo Energy? Straight from the horse's mouth, we hear about Tigo Energy (NASDAQ: TYGO) getting embroiled in a class action smackdown. Picture it: Tigo fumbles their projections, and boy does it sting. They're caught in the crossfire for allegedly puffing up their revenue expectations tied to a venture with EG4 Electronics—poised to churn out...

Continue Reading
WOLFX Super App Surges with 300% Growth Post-Launch

Updated Category News Views 4

A Fast-Paced Entry into the College Scene College life isn’t getting any easier, but the WOLFX app is blazing a trail through U.S. campuses, promising to mend some of the chaos students deal with daily. It's barely taken a breath since launching just a month ago, already knitting itself into the routine of students from 104 universities in 130 cities across America -...

Continue Reading
FuelCell's Class Action: Investors' Deadline Approaching

Updated Category News Views 3

One Rough Ride for FuelCell Investors Sometimes the market feels like a roller coaster stuck on the down-hill plunge, and right now, FuelCell Energy (NASDAQ: FCEL) investors are gripping their harnesses. The latest turmoil has investors looking at a tight November 10 deadline to decide if they want in on the securities class action shaking the ground beneath FCEL. Looming...

Continue Reading
Beyond The Bounce Expands with Pro Pickleball Star

Updated Category News Views 1

Pickleball's Power Play: The Media Move Out of the blue, the world of niche sports finds its hub. Beyond The Bounce steps up to the plate by roping in pickleball’s own Zane Navratil. The hype’s not in the spin here—this is serious business. The company plans to push the boundaries of the sport into mainstream media, or at least give it a decent shot. Zane Navratil:...

Continue Reading
HSG's Laser Tech Dazzles at FABTECH 2026

Updated Category News Views 1

Laser Innovations on Display at FABTECH 2026 Listen up, folks—FABTECH 2026 in Vegas is where HSG Laser decided to flaunt their new toys, codenamed TS2 PRO and the mystical AI CutPilot. Now, unless you've been living under a rock, you'll know HSG is all about shaking up the laser cutting scene. They've done it for two decades, and now they're pushing the envelope with...

Continue Reading
Volvo's Q3 2026 Results: Strong Growth and Margin

Updated Category News Views 4

Volvo Group's Robust Q3 Performance It's not every day that you see a company like Volvo Group churning out results that make you take a second sip of that morning coffee. But here we are—looking at Q3 2026 with growth numbers that pack a punch. You can't argue with SEK 119.5 billion in net sales, especially when organic sales growth hit 7%. That's no small feat in...

Continue Reading
Harbour BioMed's Batoclimab Injected Into Myasthenia Market

Updated Category News Views 6

China's Green Light for Batoclimab When a new drug approval hits, particularly in a crucial market like China, it's a big deal. Harbour BioMed's recent go-ahead from the National Medical Products Administration (NMPA) for their Batoclimab injection is no exception. This marks the first full clinical cycle completion of an anti-FcRn treatment for generalized myasthenia...

Continue Reading
3Srobotics Breaks Ground with North American Debut

Updated Category News Views 2

3Srobotics Steps Into the Big League The sweltering buzz of FABTECH 2026 in Las Vegas signals more than just another industry tradeshow; it's the stage upon which 3Srobotics made its North American debut. In a span shorter than it takes most companies to get serious about their business cards, 3Srobotics has already nailed three funding rounds, snagging tens of millions...

Continue Reading
class="blog__more"> More News Articles